Riboprine

DB11933InvestigationalSmall molecule

Ipa has been used in trials studying the treatment of Nausea and Surgical Site Infection.

Mechanism: Pharmacologically active on 5'-AMP-activated protein kinase
Curator reviewed
Formula / weight: C₁₅H₂₁N₅O₄ · 335.3583 g/mol (avg)
Code names: NSC-105546

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyUSVMJSALORZVDV-SDBHATRESA-NSMILES[H][C@]1(CO)O[C@@]([H])(N2C=NC3=C(NCC=C(C)C)N=CN=C23)[C@]([H])(O)[C@]1([H])O

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Marketed productAcross 1 country and 1 labeller

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Riboprine, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.